Warhound: Palmer Luckey's Startup Raises $200 Million for Gene-Edited Military Dogs

Palmer Luckey has launched a new venture that aims to genetically modify dogs for combat and reconnaissance roles. The startup, Warhound, announced on October 23, 2026, that it secured $200 million in funding to develop these enhanced animals.

The company states the engineered dogs will be trained to detect explosives and provide security for military units. Sequoia Capital is among the investors in the round. Colossal Biosciences, known for its work in de-extinction and gene editing, is collaborating with Warhound on the cloning and genetic modification processes.

The funding allows the team to begin the biological work required to alter canine genetics. This approach moves beyond traditional training methods by embedding specific traits directly into the animals' DNA. The partnership with Colossal Biosciences provides Warhound with access to existing gene-editing infrastructure and expertise.

In related science and technology news, Moderna and Merck reported that their mRNA cancer vaccine reduced deaths by 42%. The treatment also lowered the risk of melanoma returning in patients. Separately, researchers confirmed that prime editing, a technique that rewrites DNA in liver cells, has been used on its first human patient.

Cybersecurity experts assessed a set of flaws recently disclosed in PHP. They noted that the vulnerabilities are harder to exploit than initially feared, and no successful attacks have been recorded. Officials urged website operators to install patches after the bugs caused some sites to go offline. Developer Ian Landsman praised volunteer Ondřej Surý for his patching work, calling him an unsung hero of the internet.

In energy news, Google is paying customers to free up power for its data centers through a virtual power plant. A separate report stated that the company illegally cut down 250,000 trees in Finland for a data center project. In space science, researchers recreated solar flares to study the temperature of the Sun's corona.

Warhound is scheduled to begin its genetic work with the new funding. The company will work with Colossal Biosciences to produce the first batch of modified animals for testing.